Clindesse

— THERAPEUTIC CATEGORIES —
  • Vaginal infections

Clindesse Generic Name & Formulations

General Description

Clindamycin (as phosphate) 2%; vag crm.

Pharmacological Class

Lincosamide.

How Supplied

Prefilled applicator (5g )—1

Manufacturer

Mechanism of Action

Clindamycin inhibits bacterial protein synthesis at the level of the bacterial ribosome. The antibiotic binds preferentially to the 50S ribosomal subunit and affects the process of peptide chain initiation. Although clindamycin phosphate is inactive in vitro, in vivo hydrolysis converts this compound to the antibacterially active clindamycin.

Clindesse Indications

Indications

Bacterial vaginosis.

Clindesse Dosage and Administration

Adult

1 applicatorful intravaginally once.

Children

Not recommended.

Clindesse Contraindications

Contraindications

History of enteritis or colitis.

Clindesse Boxed Warnings

Not Applicable

Clindesse Warnings/Precautions

Warnings/Precautions

Monitor for pseudomembranous colitis. Do not rely on contraceptive diaphragm or condom concurrently or for 5 days after treatment. Do not have vaginal intercourse or use tampons or douches during treatment. Pregnancy (Cat.B). Nursing mothers: not recommended.

Clindesse Pharmacokinetics

Absorption

Peak serum concentration was reached ~20 hours post dosing.

Metabolism

Hepatic (CYP3A4).

Elimination

Renal. Half-life: ~3 hours.

Clindesse Interactions

Interactions

May potentiate neuromuscular blockers.

Clindesse Adverse Reactions

Adverse Reactions

Fungal vaginosis, vulvovaginal pruritus, headache.

Clindesse Clinical Trials

See Literature

Clindesse Note

Not Applicable

Clindesse Patient Counseling

See Literature